Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

CBD can either reduce inflammation and not affect hair growth at low levels or inhibit hair growth at high levels.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Both emollients effectively reduced itching and improved skin moisture in xerotic eczema.

Hair test results can be misleading due to contamination, so they shouldn't be used alone to determine drug use.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Substance abuse can cause various skin problems, including marks from injections, sores, premature aging, and increased cancer risk.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Ketoconazole shampoo is a safe and effective treatment for scalp seborrheic dermatitis.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

A new compound, BOI, can help hair grow by changing hair cycle phases and increasing certain cell contents.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Nourkrin® with Marilex® may increase hair count by 35.7% in postpartum hair loss.

Bruguiera gymnorhiza leaf extracts show potential for developing anti-inflammatory drugs.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Pexidartinib often causes liver issues and fatigue, especially in women.

AI can greatly improve medical education by personalizing learning and enhancing skills, but challenges like cost, training, and ethics need addressing.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.